Patricio Riva-Posse, MD

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia

  • 5Articles
  • 11.1KReads
  • 2024–2026Active
  • 38Collaborators
  • 9Citations

About

Patricio Riva-Posse, MD, is affiliated with the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia. Between 2024 and 2026, Dr. Riva-Posse published five articles focusing on treatment-resistant major depressive disorder (MDD) and suicide, including studies on vagus nerve stimulation (VNS) therapy and the development of consultation programs for treatment-resistant depression. The work also addresses surgical interventions as potential treatments for refractory depression. Frequent collaborators include Joao Quevedo, A. John Rush, and Anna R. Docherty.

Publications

JCP
Impact of VNS on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report
Original Research ▶ Video

Impact of VNS on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report

July 8, 2026

Findings suggest that active VNS reduces suicidal ideation (SI) and potentially induces SI remission among participants with chronic TRD and baseline SI.
, , , et al
JCP
Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report
Original Research

Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report

July 14, 2025

History of ECT use (lifetime and current episode) or TMS use (current episode) was prognostic of poorer outcomes across the total sample and superior benefit from active versus sham...
, , , et al
JCP
Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment
Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment

May 7, 2025

Consensus recommendations about the goals of a consultation for treatment-resistant depression include establishing the primary diagnosis and comorbidities, clarifying symptoms, identifying goals, documenting treatment history, identifying treatment barriers, and...
, , , et al
JCP
Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations
Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

April 28, 2025

Key practical considerations are described, including systems-level and financial issues; equity and access to TRD care for a diverse population; selecting a target population and facilitating referrals; communication between...
, , , et al
JCP
Surgical Interventions in Treatment Resistant Depression
Insights

Surgical Interventions in Treatment Resistant Depression

October 7, 2024

Patricio Riva Posse, MD, discusses advanced surgical interventions for treatment-resistant depression, including vagus nerve and deep brain stimulation. This presentation explores relapse rates, alternative therapies, and the potential for...

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe